ОбзорГрафикНовостиTraderScreen

BVT Knock-Out AMGN/  DE000VU42M96  /

Frankfurt Zert./VONT
15.11.2024  19:51:25 Изменение-1.580 Бид21:59:30 Предложение21:59:30 Базовый актив Цена исполнения Дата истечения Тип опциона
9.300EUR -14.52% -
Величина цены спроса: -		 -
Величина цены предложения: -		 Amgen Inc 184.20 USD 31.12.2078 Call
TeleTrader 12.11 Wall Street closes lower as markets brace for CPI data
TeleTrader 30.10 Amgen reports revenue of $8.5B in Q3, up 23%
TeleTrader 25.09 Dow falls 290 pts at close as S&P 500 slips from record highs
GlobeNewswire 29.08 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 28.08 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire 26.08 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
GlobeNewswire 26.08 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 15.08 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 12.08 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08.08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08.08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
TeleTrader 07.08 US closes lower with earnings in focus
TeleTrader 07.08 US turns red, Dow loses more than 200 pts
GlobeNewswire 07.08 89bio Appoints Francis Sarena as Chief Operating Officer
TeleTrader 06.08 Amgen books revenue of $8.4B in Q2, up 20%
TeleTrader 06.08 US extends premarket gains, Dow surges 250 pts
GlobeNewswire 05.08 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
TeleTrader 01.08 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 01.08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 22.07 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...
GlobeNewswire 09.07 ImCheck Appoints Stephan Braun as Chief Medical Officer
GlobeNewswire 02.07 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...
GlobeNewswire 01.07 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 27.06 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 27.06 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...